Advertisement

Topics

Astrazeneca, Aspen Enter Deal For Remaining Rights To Anaesthetic Medicines

02:44 EDT 14 Sep 2017 | FinanzNachrichten

LONDON (dpa-AFX) - Drug maker AstraZeneca plc.(AZN, AZN.L) said that it has entered into an agreement with Aspen Global Incorporated or AGI, part of the Aspen Group, under which AGI will now acqui...

Original Article: Astrazeneca, Aspen Enter Deal For Remaining Rights To Anaesthetic Medicines

NEXT ARTICLE

More From BioPortfolio on "Astrazeneca, Aspen Enter Deal For Remaining Rights To Anaesthetic Medicines"

Quick Search
Advertisement
 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

AstraZeneca
AstraZeneca is ranked 6th in the world, based on a pharmaceutical annual sales, which were valued at $32,800 million in 2009.  it is a global company, working in more than 100 countries, and employing 62,000 people, around a sixth of which are dedic...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...